MedTrace Logo

Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis

NCT07289100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-12-17

No results posted yet for this study

Summary

The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate. This study will be with adults who have either cystic fibrosis or bronchiectasis who start treatment with intravenous antibiotics (usually for around 2 weeks).

The main question it aims to answer is the change in sensor measure (such as heart rate) between the start and end of treatment for a chest infection.

No follow up visits are required for this study.

Conditions

  • Cystic Fibrosis (CF)
  • Bronchiectasis Adult

Interventions

OTHER

Non-Interventional Study

non-interventional

Sponsors & Collaborators

  • LifeArc

    collaborator OTHER

  • University of Cambridge

    collaborator OTHER

  • Department of Health, United Kingdom

    collaborator OTHER_GOV

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Papworth Hospital NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Andres Floto · University of Cambridge

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-03-31
Completion
2026-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07289100 on ClinicalTrials.gov